相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Off-Label Use and Safety of Drug Use in Vascular Anomalies
Niina Kleiber et al.
DERMATOLOGY (2021)
The effectiveness and safety of topical β-receptor blocker in treating superficial infantile haemangiomas: A meta-analysis including 20 studies
Zhenying Lin et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial
Sophie Dupuis-Girod et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Central Nervous System Effects of Oral Propranolol for Infantile Hemangioma: A Systematic Review and Meta-Analysis
Thuy Thai et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Vascular Anomalies Diagnosis of Complicated Anomalies and New Medical Treatment Options
Denise M. Adams et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2019)
To compare intralesional and oral propranolol for treating periorbital and eyelid capillary hemangiomas
Aditi Mehta et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2019)
Acute Lung Toxicity After Intralesional Bleomycin Sclerotherapy
Ana Mendez-Echevarria et al.
PEDIATRICS (2018)
A self-controlled study of intralesional injection of diprospan combined with topical timolol cream for treatment of thick superficial infantile hemangiomas
Peng Xu et al.
DERMATOLOGIC THERAPY (2018)
Pain, psychiatric comorbidities, and psychosocial stressors associated with Klippel-Trenaunay syndrome
Jamison A. Harvey et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Malignant tumors misdiagnosed as benign vascular anomalies
Federico Scorletti et al.
PEDIATRIC BLOOD & CANCER (2018)
Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: A case series
Sophie Le Sage et al.
PEDIATRIC DERMATOLOGY (2018)
Pneumocystis Jirovecii Pneumonia During Sirolimus Therapy for Kaposiform Hemangioendothelioma
Thomas B. Russell et al.
PEDIATRICS (2018)
Targeted therapy in patients with PIK3CA-related overgrowth syndrome
Quitterie Venot et al.
NATURE (2018)
Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study
Jennifer Hammer et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Effectiveness and safety of polidocanol for the treatment of hemangiomas and vascular malformations: A meta-analysis
Zhi Gao et al.
DERMATOLOGIC THERAPY (2018)
Model-based precision dosing of sirolimus in pediatric patients with vascular anomalies
Tomoyuki Mizuno et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Propranolol Treatment of Vascular Anomalies Other Than Infantile Hemangioma
Jeremy A. Goss et al.
JOURNAL OF CRANIOFACIAL SURGERY (2017)
Infantile haemangioma
Christine Leaute-Labreze et al.
LANCET (2017)
Advances in the Medical Management of Vascular Anomalies
Kiersten W. Ricci
SEMINARS IN INTERVENTIONAL RADIOLOGY (2017)
Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia A Randomized Clinical Trial
Kevin J. Whitehead et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Effect of Bevacizumab Nasal Spray on Epistaxis Duration in Hereditary Hemorrhagic Telangectasia A Randomized Clinical Trial
Sophie Dupuis-Girod et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Propranolol versus captopril in the treatment of infantile hemangioma (IH): A randomized controlled trial
Hesham Zaher et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Clinical Outcomes for Systemic Corticosteroids Versus Vincristine in Treating Kaposiform Hemangioendothelioma and Tufted Angioma
Xiaohan Liu et al.
MEDICINE (2016)
Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies
Denise M. Adams et al.
PEDIATRICS (2016)
Scoring the therapeutic effects of oral propranolol for infantile hemangioma: A prospective study comparing the Hemangioma Activity Score (HAS) with the Hemangioma Severity Scale (HSS)
Sherief R. Janmohamed et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Topical rapamycin combined with pulsed dye laser in the treatment of capillary vascular malformations in Sturge-Weber syndrome: Phase II, randomized, double-blind, intraindividual placebo-controlled clinical trial
Laura Marques et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: A double-blind, randomized, placebo-controlled trial
Dominik Riss et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)
The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies
Yin Lou et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease
S. Gaillard et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Hereditary hemorrhagic telangiectasia
P. Duffau et al.
REVUE DE MEDECINE INTERNE (2014)
Effect of propranolol vs prednisolone vs propranolol with prednisolone in the management of infantile hemangioma: A randomized controlled study
Muneer Abas Malik et al.
JOURNAL OF PEDIATRIC SURGERY (2013)
Consensus-Derived Practice Standards Plan for Complicated Kaposiform Hemangioendothelioma
Beth A. Drolet et al.
JOURNAL OF PEDIATRICS (2013)
Enhanced port-wine stain lightening achieved with combined treatment of selective photothermolysis and imiquimod
Anne Marie Tremaine et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
An Epistaxis Severity Score for Hereditary Hemorrhagic Telangiectasia
Jeffrey B. Hoag et al.
LARYNGOSCOPE (2010)
Propranolol for severe hemangiomas of infancy
Christine Leaute-Labreze et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Pain in hospitalized children: A prospective cross-sectional survey of pain prevalence, intensity, assessment and management in a Canadian pediatric teaching hospital
Elsa M. Taylor et al.
PAIN RESEARCH & MANAGEMENT (2008)
Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy -: A prospective multi-institutional trial
CM Giguère et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2002)